Cargando…
Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus
Type I interferon (IFN) drives pathology in systemic lupus erythematosus (SLE) and can be tracked via IFN-inducible transcripts in blood. Here, we examined whether measurement of circulating proteins, which enter the bloodstream from inflamed tissues, also offers insight into global IFN activity. Us...
Autores principales: | Smith, Michael A., Chiang, Chia-Chien, Zerrouki, Kamelia, Rahman, Saifur, White, Wendy I., Streicher, Katie, Rees, William A., Schiffenbauer, Adam, Rider, Lisa G., Miller, Frederick W., Manna, Zerai, Hasni, Sarfaraz, Kaplan, Mariana J., Siegel, Richard, Sinibaldi, Dominic, Sanjuan, Miguel A., Casey, Kerry A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064569/ https://www.ncbi.nlm.nih.gov/pubmed/32157125 http://dx.doi.org/10.1038/s41598-020-60563-9 |
Ejemplares similares
-
Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus
por: Rahman, Saifur, et al.
Publicado: (2019) -
IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE
por: Wang, Shu, et al.
Publicado: (2018) -
Association between anti-interferon-alpha autoantibodies and COVID-19 in systemic lupus erythematosus
por: Gupta, Sarthak, et al.
Publicado: (2020) -
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus
por: Riggs, Jeffrey M, et al.
Publicado: (2018) -
Health disparities in systemic lupus erythematosus—a narrative review
por: Hasan, Bilal, et al.
Publicado: (2022)